Sun 20 April, 2014  Drop a Visiting Card
Ranbaxy hormone to cure osteoporosis

Ranbaxy has launched a recombinant human parathyroid hormone ‘Bonista- Teriparatide’ injection for the treatment of osteoporosis, in collaboration with Virchow Biotech.

Hyderabad: Good news for aging people suffering from osteoporosis! Ranbaxy Laboratories on Thursday launched recombinant human parathyroid hormone ‘Bonista- Teriparatide' injection for the treatment of the disease, in collaboration with Virchow Biotech.

According to the company, the product has been indigenously researched at Virchow in Hyderabad and developed in association with the Department of Science and Technology in India.

Commenting on the launch of the product, Ranbaxy Senior VP and Regional Director (Asia and CIS) Sanjeev I Dani said that with growing longevity, Osteoporosis a condition characterised by loss of bone mass, would gain increased attention.

Dani claimed that Bonista is a quality bio-generic therapeutic options to doctors and an affordable and efficacious product to patients.

According to the company, with the life span of an average Indian going up, the country is witnessing an increase in the number of osteoporosis cases; with an estimated 50 per cent Indian women having osteoporosis, the actual number translates to over 30 million.

Experts suggests that one of the reasons could be that the majority of Indians have low vitamin D status and are on low dietary calcium which makes them prone to bone diseases.
—iGovernment Bureau

This is great news--when will it be available to the general public , who like myself have osteoporosis ?

Post new comment

Content limited to 50 characters, remaining: 50
Content limited to 1500 characters, remaining: 1500
This question is for testing whether you are a human visitor and to prevent automated spam submissions.
Enter the characters shown in the image.
Todays Main News »

Click below for your free email iGovernment newsletter